Buchumschlag

Correction to Effectively Leveraging RWD for External Controls: A Systematic Literature Review of Regulatory and HTA Decisions

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2024
Schlagworte:	Clinical Pharmacology & Therapeutics
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Corrections to “Effectively Leveraging RWD for External Controls: A Systematic Literature Review of Regulatory and HTA Decisions”
Veröffentlicht: (2024)

Questioning Conclusions and Statements on the German HTA System: A Critical Perspective
von: Jörg Tomeczkowski, et al.
Veröffentlicht: (2024)

Reply to: “Questioning Conclusions and Statements on the German HTA System: A Critical Perspective”
von: James Harnett, et al.
Veröffentlicht: (2024)

Progress in Pharmacometrics Implementation and Regulatory Integration in Africa: A Systematic Review
von: Bonginkosi S'fiso Ndzamba, et al.
Veröffentlicht: (2024)

Real‐World Evidence to Inform Regulatory Decision Making: A Scoping Review
von: Marieke S. Jansen, et al.
Veröffentlicht: (2024)

Agreement about Availability of Alternative Treatments for Innovative Drugs Assessed by the EMA and HTA Organizations
von: Jorge Madrid Paredes, et al.
Veröffentlicht: (2024)

Harmonizing HTA Evidence Needs and Expectations: Challenges and Opportunities to Improve Evidence Generation, Ensure Access and Affordability
von: Sarah K. Emond, et al.
Veröffentlicht: (2025)

The Use of Real‐World Evidence for Regulatory Decisions in China
von: Jiayue Xu, et al.
Veröffentlicht: (2024)

Real‐World Evidence in Regulatory Decision Making: Time for Evidence Integration
von: Rebecca A. Miksad
Veröffentlicht: (2024)

FRAME: Framework for Real‐World Evidence Assessment to Mitigate Evidence Uncertainties for Efficacy/Effectiveness – An Evaluation of Regulatory and Health Technology Assessment Decision Making
von: Gianmario Candore, et al.
Veröffentlicht: (2025)

Advancing Principled Pharmacoepidemiologic Research to Support Regulatory and Healthcare Decision Making: The Era of Real‐World Evidence
von: Rohini K. Hernandez, et al.
Veröffentlicht: (2025)

Biomarker Utilization for Regulatory Decision Making: A Landscape Analysis of Neurological Drug Products Approved by FDA (2008–2024)
von: Dahee Jung, et al.
Veröffentlicht: (2025)

A Framework for Assessing the Viability of External Control for a Single‐Arm Trial
von: Victor A. Kiri
Veröffentlicht: (2026)

Enhancing External Control Arm Analyses through Data Calibration and Hybrid Designs
von: Sebastian Schneeweiss
Veröffentlicht: (2024)

Risk versus Benefit of Tyrosine Kinase Inhibitors for Hepatocellular Carcinoma: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials
von: Tania Payo‐Serafín, et al.
Veröffentlicht: (2024)

Supplementing Single‐Arm Trials with External Control Arms—Evaluation of German Real‐World Data
von: Martin Russek, et al.
Veröffentlicht: (2025)

Major Adverse Cardiac Events with Ondansetron: A Systematic Review
von: Michael Cristian Garcia, et al.
Veröffentlicht: (2025)

A Systematic Review on Disease‐Modifying Therapies in Parkinsonian Disorders
von: Pepijn P.N.M. Eijsvogel, et al.
Veröffentlicht: (2026)

Dosage Optimization: A Regulatory Perspective for Developing Oncology Drugs
von: Atiqur Rahman, et al.
Veröffentlicht: (2024)

Thinking Three‐Dimensionally: A Self‐ and Externally‐Controlled Approach to Screening for Drug–Drug–Drug Interactions Among High‐Risk Populations
von: Emily K. Acton, et al.
Veröffentlicht: (2024)

Information Bias in Electronic Health Records and Administrative Claims Data: A Targeted Review of the Recent Literature
von: Patrick J. Arena, et al.
Veröffentlicht: (2025)

Congenital and Fetal Effects After Mifepristone Exposure and Continuation of Pregnancy: A Systematic Review
von: Joseph V. Turner, et al.
Veröffentlicht: (2024)

Regulatory Issues of Platform Trials: Learnings from EU‐PEARL
von: Quynh Lan Nguyen, et al.
Veröffentlicht: (2024)

Correction to “Optimizing Hydroxychloroquine Dosing for Patients With COVID‐19: An Integrative Modeling Approach for Effective Drug Repurposing”
Veröffentlicht: (2025)

Efficacy and Safety of Janus Kinase Inhibitors in Patients with Vitiligo: A Systematic Review and Meta‐Analysis
von: Fan Huang, et al.
Veröffentlicht: (2024)

QTc Interval Changes in Preeclampsia vs. Normal Pregnancy: A Systematic Review and Meta‐Analysis
von: Omar A. Aboshady, et al.
Veröffentlicht: (2025)

Extended Model‐Informed Drug Development: Beyond Clinical Trials and Regulatory Approval
von: Mohamed A. Kamal, et al.
Veröffentlicht: (2024)

The Evolution of Drug Regulatory Sciences in the Netherlands: More than a Country Report
von: Anna M. G. Pasmooij, et al.
Veröffentlicht: (2024)

Advancing Pharmacoequity Globally: Reflections from the ASCPT Development, Regulatory, and Outcomes Network
von: Priya Jayachandran, et al.
Veröffentlicht: (2026)

Regulatory Interactions and Learnings— RADIAL the Trials@Home Proof‐of‐Concept Trial on Decentralization
von: Helga Gardarsdottir, et al.
Veröffentlicht: (2025)

Capability Development in the European Medicines Regulatory Network—A European Learning Needs Analysis and Survey Study
von: Naomi Beard, et al.
Veröffentlicht: (2025)

High Virologic Suppression and Favorable Profiles of Two‐Drug Antiretroviral Regimens in Africa: A Systematic Review of Current Evidence
von: Paul Achile Akpa, et al.
Veröffentlicht: (2025)

Characteristics of Drugs from Non‐Global Companies for Hematologic Malignancies and Impact on Global Regulatory Approval
von: Kensuke Matsuda, et al.
Veröffentlicht: (2024)

The Rare Disease Moonshot: Paradigms Shift, Translational Medicine, and Regulatory Science for the World's Rarest Conditions
von: Cécile Ollivier, et al.
Veröffentlicht: (2024)

Impact of Regulatory Post‐Market Safety Advisories on Prescribing Practices: An Interrupted Time Series Analysis
von: Seonji Kim, et al.
Veröffentlicht: (2025)

Regulatory Perspective Based on Survey of Relationship Between Biopharmaceutical Characteristics and Food Effects on Systemic Pharmacokinetics
von: Naoko Honma, et al.
Veröffentlicht: (2025)

Regulatory Approval of CAR‐T Cell and BsAb Products for Lymphoid Neoplasms in the US, EU, and Japan
von: Kensuke Matsuda, et al.
Veröffentlicht: (2025)

A Systematic Review of the Costs of Drug‐Associated Acute Kidney Injury and Potential Cost Savings With Nephrotoxin Stewardship Prevention Strategies
von: Britney A. Stottlemyer, et al.
Veröffentlicht: (2024)

Risk of Hypoglycemia Associated With Concomitant Use of Insulin Secretagogues and ACE Inhibitors in Adults With Type 2 Diabetes: A Systematic Review
von: Patricia Y. Chu, et al.
Veröffentlicht: (2024)

The Type of Follicle‐Stimulating Hormone Medication Given for In Vitro Fertilization Impacts Oocyte Retrieval: A Systematic Review and Meta‐Analysis
von: Toni J.F. Michael, et al.
Veröffentlicht: (2025)